A minimally invasive treatment gives hope to people diagnosed with mitral regurgitation - a problem with the valve between the ventricle and the atrium of the heart
New procedure improves outcomes for heart failure patients - daily science news in short - medical

A new clinical trial reported that a minimally invasive procedure called transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients. The trial enrolled 614 heart failure patients with moderate-to-severe or severe specific heart conditions at 78 sites in the United States and Canada. The patients who had the new minimally invasive procedure had 47% fewer heart failure-related hospitalizations and 38% fewer deaths than those who were managed medically. “Patients with heart failure… now have substantially more hope because we can improve their quality of life and survival” Gregg Stone, co-principal investigator of the trial, said.

Read the full story: Columbia University
Scientific publication: The New England Journal of Medicine